SIRT1 and pulmonary arterial hypertension: Taken together, these findings underscore that impaired SIRT1-dependent signaling contributes to the overexpression of inflammatory genes in PAH, while therapeutic strategies aimed at restoring SIRT1 activity may provide significant anti-inflammatory and vasoprotective benefits.